NF-&kgr;B in Type 1 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|10|3|208-217

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.10, Iss.3, 2011-06, pp. : 208-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Naturally Occurring NF-&kgr;B Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 945-951

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-&kgr;B

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 3, 2004-01 ,pp. : 317-324

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Arginate Pretreatment Attenuates Pulmonary NF-&kgr;B and AP-1 Activation Induced by Hemorrhagic Shock via Heme Oxygenase-1 Induction

By  

Medicinal Chemistry, Vol. 2, Iss. 3, 2006-05 ,pp. : 272-274

Bentham Science Publishers

Access to resources Recommend Favorite

Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-&kgr;B) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis

By  

Current Cancer Drug Targets, Vol. 7, Iss. 4, 2007-06 ,pp. : 325-334

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr; B and Rheumatic Diseases

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 359-372

Bentham Science Publishers

Access to resources Recommend Favorite